Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Drug Intelligence & Clinical Pharmacy
|
January 1, 1986
High-dose moxalactam in gram-negative pneumonia
B H Ackerman, J C Rotschafer, R W Tofte
Pharmacotherapy
|
May 1, 1997
The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient
K M Kramer, D J Skaar, B H Ackerman
Biochemical and Biophysical Research Communications
|
December 31, 1990
The N-terminus, C-terminus, and vessel dilator of the ANF prohormone are present in the urine and increase with ventricular fibrillation
R P Wyeth, B H Ackerman, D L Vesely
Postgraduate Medicine
|
February 1, 1984
Aminoglycoside therapy. Improving patient response and safety
B H Ackerman, G R Bailie, D E Zaske
DICP : the Annals of Pharmacotherapy
|
December 1, 1990
Postoperative analgesic requirements following flumazenil administration
K M Olsen, C S Pablo, B H Ackerman
Antimicrobial Agents and Chemotherapy
|
August 1, 1992
Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response
B H Ackerman, A M Vannier, E B Eudy
DICP : the Annals of Pharmacotherapy
|
July 1, 1991
Accumulation of 3-hydroxyquinidine following chronic quinidine therapy
B H Ackerman, K M Olsen, A A Pappas
Archives of Pathology & Laboratory Medicine
|
May 1, 1992
Disseminated Nocardia asteroides diagnosed by blood culture in a patient with disseminated histoplasmosis
A M Vannier, B H Ackerman, L F Hutchins
Therapeutic Drug Monitoring
|
May 1, 1990
Errors in assuming a one-compartment model for vancomycin
B H Ackerman, K M Olsen, C B Padilla
Therapeutic Drug Monitoring
|
January 1, 1989
Variance in quinidine maintenance dose prediction using four dosing methods
K O'Neill, B Hurt, K M Olsen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Drug Intelligence & Clinical Pharmacy
|
January 1, 1986
High-dose moxalactam in gram-negative pneumonia
B H Ackerman, J C Rotschafer, R W Tofte
Pharmacotherapy
|
May 1, 1997
The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient
K M Kramer, D J Skaar, B H Ackerman
Biochemical and Biophysical Research Communications
|
December 31, 1990
The N-terminus, C-terminus, and vessel dilator of the ANF prohormone are present in the urine and increase with ventricular fibrillation
R P Wyeth, B H Ackerman, D L Vesely
Postgraduate Medicine
|
February 1, 1984
Aminoglycoside therapy. Improving patient response and safety
B H Ackerman, G R Bailie, D E Zaske
DICP : the Annals of Pharmacotherapy
|
December 1, 1990
Postoperative analgesic requirements following flumazenil administration
K M Olsen, C S Pablo, B H Ackerman
Antimicrobial Agents and Chemotherapy
|
August 1, 1992
Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response
B H Ackerman, A M Vannier, E B Eudy
DICP : the Annals of Pharmacotherapy
|
July 1, 1991
Accumulation of 3-hydroxyquinidine following chronic quinidine therapy
B H Ackerman, K M Olsen, A A Pappas
Archives of Pathology & Laboratory Medicine
|
May 1, 1992
Disseminated Nocardia asteroides diagnosed by blood culture in a patient with disseminated histoplasmosis
A M Vannier, B H Ackerman, L F Hutchins
Therapeutic Drug Monitoring
|
May 1, 1990
Errors in assuming a one-compartment model for vancomycin
B H Ackerman, K M Olsen, C B Padilla
Therapeutic Drug Monitoring
|
January 1, 1989
Variance in quinidine maintenance dose prediction using four dosing methods
K O'Neill, B Hurt, K M Olsen, et al.
Page
of 5